Trend AnalysisMedicine & Health

Organ-on-Chip: Replacing Animal Testing with Microphysiological Systems

Drug development fails ~90% of the time in clinical trials, costing the industry ~$2 billion per approved drug. A primary reason: animal models poorly predict human toxicity and efficacy. Organ-on-chi...

By Sean K.S. Shin
This blog summarizes research trends based on published paper abstracts. Specific numbers or findings may contain inaccuracies. For scholarly rigor, always consult the original papers cited in each post.

The Question

Drug development fails ~90% of the time in clinical trials, costing the industry ~$2 billion per approved drug. A primary reason: animal models poorly predict human toxicity and efficacy. Organ-on-chip (OoC) devices โ€” microfluidic systems that culture human cells under physiologically relevant conditions (flow, stretch, air-liquid interface) โ€” promise to bridge this translational gap. The 2022 FDA Modernization Act 2.0 removed the legal requirement for animal testing, opening the regulatory door for OoC-based preclinical evidence. Can these miniature organs on microchips replace animal studies?

Landscape

Reyes et al. (2024) authored a landmark review on standardisation in microphysiological systems (MPS), identifying the key barriers to regulatory acceptance: lack of standard operating procedures, absence of reference compounds for validation, and no consensus on what "qualified" means for an OoC device. Their roadmap proposed a three-tier qualification framework: (1) analytical validation (does the chip measure what it claims?), (2) biological validation (does it reproduce known biology?), and (3) clinical validation (does it predict clinical outcomes better than existing models?).

J. Wang et al. (2025) achieved a remarkable engineering feat: an eighteen-organ MPS coupled with miniaturised vascular networks and an excretion system. This "body-on-a-chip" connects organ modules through perfusable channels that mimic systemic circulation, enabling the study of multi-organ drug interactions, metabolic processing (liver), excretion (kidney), and off-target toxicity (heart, brain) simultaneously.

Truong et al. (2025) reviewed OoC models for reproductive tissues โ€” an area where animal models are particularly poor predictors of human outcomes due to species-specific differences in placentation, hormonal cycling, and pregnancy physiology. With FDA Modernization Act 2.0 explicitly permitting non-animal alternatives, reproductive toxicology may be an early adoption domain.

Key Claims & Evidence

<
ClaimEvidenceVerdict
OoC devices better predict human drug toxicity than animal modelsEmulate lung-on-chip predicted pulmonary toxicity missed by animal studiesSupported for specific organ models; systematic comparison ongoing
Standardisation is the primary barrier to regulatory acceptanceLack of SOPs, reference compounds, and qualification criteria (Reyes et al. 2024)Confirmed; active standardisation efforts underway (ISO, NIST)
Multi-organ systems capture systemic drug interactions18-organ MPS with vascular and excretory coupling (J. Wang et al. 2025)Demonstrated technically; predictive validity not yet established
FDA Modernization Act 2.0 enables OoC regulatory submissionsLegal framework now permits non-animal preclinical evidenceConfirmed; regulatory science guidance still developing

Open Questions

  • Immune component: Most OoC devices lack circulating immune cells. Can immune-competent chips predict immunotoxicity and drug-induced hypersensitivity reactions?
  • Throughput: Current OoC fabrication is artisanal. Can injection moulding and automated cell seeding achieve the throughput needed for pharmaceutical screening (thousands of compounds)?
  • Patient-specific chips: Can OoC devices made from individual patient iPSCs guide personalised therapy decisions in oncology and rare diseases?
  • Economic case: At what point does the cost of OoC testing drop below animal testing while delivering better predictive accuracy?

    • Referenced Papers

    • [1] Reyes, D.R. et al. (2024). From animal testing to in vitro systems: standardization in MPS. Lab on a Chip. DOI: 10.1039/d3lc00994g
    • [2] Wang, J. et al. (2025). An eighteen-organ microphysiological system with vascular and excretion coupling. Microsystems & Nanoengineering. DOI: 10.1038/s41378-025-00933-3
    • [3] Truong, N. et al. (2025). Modeling reproductive tissues using organ-on-chip platforms. Frontiers in Bioengineering and Biotechnology, 13, 1568389. DOI: 10.3389/fbioe.2025.1568389
    • [4] Behrens, S. et al. (2024). Mechanical stimulation of collagen membranes for OoC applications. Current Directions in Biomedical Engineering. DOI: 10.1515/cdbme-2024-2017
    • [5] Bacon, J. et al. (2025). Porcine intestinal organoids in organ-on-a-chip MPS. Biochemistry and Biophysics Reports. DOI: 10.1016/j.bbrep.2025.102036

    References (5)

    Reyes, D. R., Esch, M. B., Ewart, L., Nasiri, R., Herland, A., Sung, K., et al. (2024). From animal testing to in vitro systems: advancing standardization in microphysiological systems. Lab on a Chip, 24(5), 1076-1087.
    DOIScholar
    Wang, J., Zhang, H., Qu, Y., Yang, Y., Xu, S., Ji, Z., et al. (2025). An eighteen-organ microphysiological system coupling a vascular network and excretion system for drug discovery. Microsystems & Nanoengineering, 11(1).
    DOIScholar
    Truong, N., Zahra, A., Lintao, R. C. V., Chauhan, R., Bento, G. F., Vidal Jr., M., et al. (2025). Modeling reproductive and pregnancy-associated tissues using organ-on-chip platforms: challenges, limitations, and the high throughput data frontier. Frontiers in Bioengineering and Biotechnology, 13.
    DOIScholar
    Behrens, S., Golde, J., Schรถps, Y., Polk, C., Seidel, G., Goerke, F., et al. (2024). Mechanical stimulation and monitoring of artificial collagen membranes for Organ-on Chip applications. Current Directions in Biomedical Engineering, 10(4), 70-73.
    DOIScholar
    Bacon, J., Kitchel, H., Stutz, J., Chen, J. J. H., Smith, A., Van Horn, R. D., et al. (2025). Porcine intestinal organoids cultured in an organ-on-a-chip microphysiological system. Biochemistry and Biophysics Reports, 42, 102036.
    DOIScholar

    Explore this topic deeper

    Search 290M+ papers, detect research gaps, and find what hasn't been studied yet.

    Click to remove unwanted keywords

    Search 8 keywords โ†’